விநியோகிக்கப்பட்டது உயிர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Charles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Charles River Laboratories International, Inc (NYSE:CRL) - Charles River Acquires Viral Vector Player For $350M
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Charles River says the combination of Distributed Bio’s platform, which the CRO recently acquired, with its own downstream characterization capabilities, enables identification of the best lead candidate in CAR T cell therapies – balancing efficacy and safety for optimal therapeutic outcome.
Teams from Charles River and Distributed Bio presented research at AACR 2021 in April detailing how their technology and expertise benefits CAR T cell therapy developers.
Distributed Bio’s phage-display libraries (SuperHuman 2.0 and Tungsten) have been designed to be biophysically stable and non-immunogenic. Their size and clonal diversity, coupled with the use of streamlined work-flows, enable the rapid identification of large panels of sequence-unique binders which can then be assessed for CAR suitability by exploiting the integrated approach offered by Distrbuted Bio’s partnership with Charles River, they explained.
Welcome to Twist Bioscience Fiscal 2021 Second Quarter Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference call over to Jim Thorburn, Chief Financial Officer.
Jim Thorburn
Chief Financial Officer
Thank you, operator. Good afternoon, everyone. I d like to thank all of you for joining us today for Twist Bioscience conference call to review our fiscal 2021 second quarter financial results and business progress. We did issue our financial results earlier this afternoon, which is available at our website at www.twistbioscience.com. With me on today s call is Dr. Emily Leproust, CEO and Co-Founder of Twist. Emily will begin with a review of our recent progress in Twist businesses. I will report on our financial and operational performance. And Emily will discuss our upcoming milestones and direction. We will then open the call for questions. As a reminder, this call is being recorded. The audio portion will be archived in the Investors
Charles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Charles River Laboratories International Inc (NYSE: CRL)
Popular Searches
Operator
Good day, and thank you for standing by. Welcome to the Charles River Laboratories First Quarter 2021 Earnings Conference Call. [Operator Instructions] [Operator Instructions]
I would now like to hand the conference over to your speaker today, Todd Spencer, Vice President of Investor Relations. Thank you. Please go ahead, sir.SPONSORED:
10 stocks we like better than Charles River Laboratories
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
vimarsana © 2020. All Rights Reserved.